Full Press Release Details
Country Healthcare Announces Fourth Quarter and Full Year 2018 Financial
BOCA RATON, Fla.--(BUSINESS WIRE)--February 27, 2019--Cross Country
Healthcare, Inc. (the "Company") (NASDAQ: CCRN) today announced
financial results for its fourth quarter and full year ended
SELECTED FINANCIAL INFORMATION:
| Dollars are in thousands, except per share amounts | Q4 2018 | Variance Q4 2018 vs Q4 2017 | Variance Q4 2018 vs Q3 2018 | Full Year 2018 | Variance 2018 vs 2017 | |||||||||||||||||||||||||||||||||||||||||
| Revenue | $200,907 | (9)% | 0% | $816,484 | (6)% | |||||||||||||||||||||||||||||||||||||||||
| Gross profit margin* | 25.2% | (130) bps | (50) bps | 25.7% | (70) bps | |||||||||||||||||||||||||||||||||||||||||
| Net loss attributable to common shareholders | $(19,691) | (170)% | NM | $(16,951) | (145)% | |||||||||||||||||||||||||||||||||||||||||
| Diluted EPS | $(0.55) | $(1.32) | $(0.54) | $(0.48) | $(1.49) | |||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA* | $6,153 | (50)% | (24)% | $31,362 | (28)% | |||||||||||||||||||||||||||||||||||||||||
| Adjusted EPS* | $0.00 | $(0.17) | $(0.02) | $0.12 | $(0.49) | |||||||||||||||||||||||||||||||||||||||||
| Cash flows from operations | $(760) | (105)% | (120)% | $20,997 | (54)% | |||||||||||||||||||||||||||||||||||||||||
| *Refer to accompanying tables and discussion of Non-GAAP financial measures below. NM - Not meaningful |
"I am thrilled to be back with the company I co-founded to see it
through the next phase in its evolution," said Kevin C. Clark, President
and Chief Executive Officer. "2018 was a challenging year on several
fronts, with softer demand in the first half and unexpected higher
costs, but I am looking to the future," he added. "Our primary focus is
to drive operational improvements to return the company to growth and
improved profitability. Achieving this goal will require a laser focus
on productivity and technology across our entire business."
Fourth quarter consolidated revenue was $200.9 million, a decrease of 9%
year-over-year and up slightly sequentially. Consolidated gross profit
margin was 25.2%, down 130 basis points year-over-year and 50 basis
points sequentially. Net loss attributable to common shareholders was
$19.7 million compared to net income of $28.0 million in the prior year
and a net loss of $0.4 million in the prior quarter. Diluted EPS was a
loss of $0.55 per share compared to income of $0.77 per share in the
prior year and a loss of $0.01 per share in the prior quarter. Adjusted
EBITDA was $6.2 million or 3.1% of revenue, as compared with $12.3
million or 5.6% of revenue in the prior year, and $8.1 million or 4.0%
of revenue in the prior quarter. Adjusted EPS was $0.00 in the current
quarter as compared to income of $0.17 in the prior year and $0.02 in
For the year ended December 31, 2018, consolidated revenue was $816.5
million, a decrease of 6% year-over-year, 9% on a pro forma basis.
Consolidated gross profit margin was 25.7%, down 70 basis points
year-over-year. Net loss attributable to common shareholders was $17.0
million, or a loss of $0.48 per diluted share, compared to net income of
$37.5 million, or income of $1.01 per diluted share, in the prior year.
Adjusted EBITDA was $31.4 million or 3.8% of revenue, as compared with
$43.4 million or 5.0% of revenue in the prior year. Adjusted EPS was
$0.12 compared to $0.61 in the prior year.
Fourth quarter and full year results for 2018 and 2017 were impacted by
Physician Staffing pretax noncash impairment charges of $22.4 million
and $14.4 million, as well as noncash income tax benefits of $6.0
million and $36.8 million, respectively. 2018 and 2017 included income
tax benefits related to the impairment charges. 2017 also included the
reversal of substantially all of the Company's valuation allowances on
its deferred tax assets, as well as income tax expense attributable to
the re-measurement of deferred tax assets under the 2017 Tax Cuts and
Quarterly Business Segment Highlights
Nurse and Allied Staffing
Revenue from Nurse and Allied Staffing was $179.5 million, a 7% decrease
year-over-year and an increase of 2% sequentially. Contribution income
was $16.2 million, down from $19.2 million in the prior year, and down
sequentially from $16.5 million in the prior quarter. Average field FTEs
decreased to 7,056 from 7,521 in the prior year and increased from 6,953
in the prior quarter. Revenue per FTE per day was $277 compared to $280
in the prior year and $276 in the prior quarter.
Revenue from Physician Staffing was $18.3 million, a decrease of 19%
year-over-year and 14% sequentially. Contribution income was $0.6
million, down from $1.0 million in the prior year and $1.3 million in
the prior quarter. Total days filled were 11,663 as compared with 14,852
in the prior year and 13,375 in the prior quarter. Revenue per day
filled was $1,565 as compared with $1,519 in the prior year and $1,582
in the prior quarter.
Other Human Capital Management Services
Revenue from Other Human Capital Management Services was $3.1 million, a
decrease of 7% year-over-year and 2% sequentially. Segment contribution
loss was $0.1 million for the current quarter compared to a loss of $0.2
million in the prior year, and income of $0.1 million in the prior
Cash Flow and Balance Sheet Highlights
Cash flow used in operating activities for the current quarter was $0.8
million compared to cash provided of $16.8 million in the prior year.
During the fourth quarter, the Company made principal payments of $7.4
million, including an optional prepayment of $5.0 million. Cash flow
provided by operating activities for the full year was $21.0 million
compared to $45.5 million in the prior year.
At December 31, 2018, the Company had $16.0 million in cash and cash
equivalents and a principal balance of $83.9 million on its Term Loan.
There were no amounts drawn on the Company's revolving credit facility
and there were $20.6 million of letters of credit outstanding as of
Outlook for First Quarter 2019
The guidance below applies only to management's expectations for the
first quarter of 2019.
| Q1 2019 Range | Year-over-Year | Sequential | |||||||||||||
| Change | Change | ||||||||||||||
| Revenue | $195 million - $200 million | (7)% - (5)% | (3)% - 0% | ||||||||||||
| Gross Profit Margin | 24.0% - 24.5% | (160) bps - (110) bps | (120) bps - (70) bps | ||||||||||||
| Adjusted EBITDA | $3.0 million - $4.0 million | (64)% - (52)% | (51)% - (35)% | ||||||||||||
| Adjusted EPS | $(0.04) - $(0.02) | $(0.10) - $(0.08) | $(0.04) - $(0.02) |
The estimates above are based on current management expectations and, as
such, are forward-looking and actual results may differ materially. The
above ranges do not include the potential impact of any future
divestitures, mergers, acquisitions or other business combinations, any
changes in debt structure, or any future share repurchases. See
accompanying Non-GAAP financial measures and tables below.
INVITATION TO CONFERENCE CALL
The Company will hold its quarterly conference call on Wednesday,
February 27, 2019, at 5:00 P.M. Eastern Time to discuss its fourth
quarter and full year 2018 financial results. This call will be webcast
live and can be accessed at the Company's website at www.crosscountryhealthcare.com
or by dialing 888-566-1099 from anywhere in the U.S. or by dialing
773-799-3716 from non-U.S. locations - Passcode: Cross Country. A replay
of the webcast will be available from February 27, 2019 through March
13, 2019 at the Company's website and a replay of the conference call
will be available by telephone by calling 800-839-5574 from anywhere in
the U.S. or 203-369-3669 from non-U.S. locations - Passcode: 2019.
ABOUT CROSS COUNTRY HEALTHCARE
Cross Country Healthcare is a national leader in providing innovative
healthcare workforce solutions and staffing services. Our solutions
leverage our nearly 40 years of expertise and insight to assist clients